Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway

BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can effectively alleviate liver fibrosis, which is a pathological injury caused by various chronic liver diseases. This study aimed to investigate the antifibrotic effects of BMSCs and elucidate the underlying mechanism by which BMSCs affect liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaoguo, Zhou, Song, Zhang, Ya, Zhao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017036/
https://www.ncbi.nlm.nih.gov/pubmed/35440002
http://dx.doi.org/10.1186/s13027-022-00432-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017036/
https://www.ncbi.nlm.nih.gov/pubmed/35440002
http://dx.doi.org/10.1186/s13027-022-00432-4

Ejemplares similares